Global Intravenous (IV) Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In 2017, BD launched a new IV medication safety solution at the European Association of Hospital Pharmacists (EAHP, Cannes) congress to improve patient safety. This product is designed to prevent medication administration errors.

• In October 2017, ICU Medical, Inc. acquired Pfizer's Hospira infusion systems (HIS, U.S.) business segment with a comprehensive portfolio of complete IV therapy from pumps to solutions.

The global intravenous (IV) equipment market is experiencing significant growth, driven by several factors. Firstly, the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has increased the demand for IV therapy as an effective treatment option. This trend is particularly pronounced in aging populations across developed countries where the incidence of chronic conditions is higher.

Technological advancements in IV equipment are enhancing the efficiency and safety of administering intravenous therapies. Innovations such as smart pumps, which can accurately deliver fluids and medications while minimizing the risk of errors, are gaining traction in healthcare settings. Additionally, the development of wearable IV devices is providing patients with greater mobility and convenience, further fueling market growth.

The COVID-19 pandemic has underscored the importance of IV therapy in the management of critically ill patients. Hospitals and healthcare facilities have ramped up their infrastructure to accommodate the surge in demand for IV equipment, including infusion pumps, catheters, and IV sets. This heightened focus on emergency preparedness and critical care has bolstered the adoption of IV equipment worldwide.

Challenges such as product recalls, stringent regulatory requirements, and pricing pressures pose constraints to market expansion. Manufacturers are investing in research and development to address these challenges and introduce innovative solutions that meet regulatory standards while remaining cost-effective. Overall, with the continued emphasis on patient safety and quality of care, the global IV equipment market is poised for sustained growth in the coming years.

Global Intravenous (IV) Equipment Segment Analysis

In this report, the Global Intravenous (IV) Equipment Market has been segmented by Type, and Geography.

Global Intravenous (IV) Equipment Market, Segmentation by Type

The Global Intravenous (IV) Equipment Market has been segmented by Type into IV Catheter, Infusion Pumps, Securement Devices, Administration Sets and Drip Chambers.

One of the primary segments within this market is IV Catheters. These devices serve as crucial conduits for delivering fluids, medications, or blood products directly into a patient's bloodstream. IV catheters come in different sizes and materials to accommodate different patient needs and medical procedures, contributing significantly to the efficiency and safety of intravenous therapy.

Another integral component of the IV equipment market is Infusion Pumps. These devices are designed to deliver fluids, such as medications or nutrients, into a patient's body in controlled amounts. Infusion pumps play a critical role in various medical settings, including hospitals, clinics, and home care, ensuring precise delivery of medications and fluids while minimizing the risk of human error. Continuous advancements in technology have led to the development of sophisticated infusion pumps capable of delivering multiple medications simultaneously or adjusting infusion rates based on patient parameters.

Securement Devices represent another segment within the IV equipment market, focusing on the secure attachment of IV catheters and other devices to a patient's skin. These devices prevent accidental dislodgement of IV lines, reducing the risk of complications and ensuring uninterrupted therapy. Securement devices come in various forms, including adhesive dressings, securement clips, and catheter stabilization devices, offering healthcare providers options to meet specific patient needs and preferences.

Administration Sets and Drip Chambers round out the segmentation of the Global Intravenous (IV) Equipment Market. Administration sets serve as the connecting link between IV fluids or medications and the patient's IV catheter or infusion pump. Drip chambers, a crucial component of administration sets, regulate the flow of fluids into the IV line, ensuring precise delivery rates and preventing air from entering the bloodstream. As essential elements of intravenous therapy, administration sets and drip chambers undergo continuous refinement to enhance patient safety and treatment efficacy. Together, these segments contribute to a dynamic and evolving IV equipment market, driven by innovation and a commitment to improving patient care outcomes.

Global Intravenous (IV) Equipment Market, Segmentation by End User

The Global Intravenous (IV) Equipment Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers and Others.

Hospitals constitute a significant end user segment in the global IV equipment market. With their comprehensive range of medical services and infrastructure, hospitals are the primary setting for administering intravenous therapies. They handle a wide array of patient cases, ranging from critical care to routine procedures, necessitating the extensive use of IV equipment for fluid administration, medication delivery, and nutritional support.

Ambulatory Surgical Centers (ASCs) represent another key end user segment contributing to the growth of the IV equipment market. These facilities offer outpatient surgical procedures that do not require overnight hospitalization. IV equipment plays a crucial role in ASCs, facilitating the delivery of anesthesia, antibiotics, and other medications during surgical interventions, thereby supporting efficient patient care and recovery within a shorter timeframe compared to traditional hospital settings.

The Others category encompasses various healthcare settings such as clinics, nursing homes, and home healthcare setups. This segment reflects the growing trend towards decentralized healthcare delivery, where IV therapy is administered outside of traditional hospital settings. The rising preference for home-based treatments, driven by factors like patient convenience, cost-effectiveness, and advances in technology enabling safe and effective IV administration in non-hospital settings, further contributes to the demand for IV equipment across diverse end user segments.

Global Intravenous (IV) Equipment Market, Segmentation by Geography

In this report, the Global Intravenous (IV) Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Intravenous (IV) Equipment Market Share (%), by Geographical Region, 2024

The North American region holds a prominent position in the global intravenous (IV) equipment market, primarily driven by the advanced healthcare infrastructure, high adoption rates of novel medical technologies, and substantial investment in research and development activities. The presence of key market players and favorable reimbursement policies further contribute to the region's dominance. Moreover, the rising prevalence of chronic diseases, coupled with an aging population, underscores the increasing demand for IV equipment in this region.

In Europe, the IV equipment market is characterized by stringent regulatory frameworks, technological advancements, and growing healthcare expenditure. Countries like Germany, France, and the UK are at the forefront of innovation, with a strong emphasis on patient safety and treatment efficacy. Additionally, the rising healthcare awareness among the populace and the expanding geriatric population drive market growth in this region. However, economic uncertainties and healthcare budget constraints in certain European countries pose challenges to market expansion.

The Asia Pacific region is witnessing rapid growth in the IV equipment market, fueled by improving healthcare infrastructure, increasing disposable income, and expanding access to healthcare services. Countries like China, India, and Japan are major contributors to market growth, supported by government initiatives aimed at enhancing healthcare accessibility and affordability. Additionally, the escalating burden of infectious diseases and the rising demand for advanced medical treatments propel the adoption of IV equipment in the region.

In the Middle East and Africa (MEA) region, the IV equipment market is characterized by a growing emphasis on healthcare modernization and infrastructure development. Countries in the Gulf Cooperation Council (GCC) region, such as Saudi Arabia and the UAE, are witnessing substantial investments in healthcare facilities, driving the demand for IV equipment. Furthermore, the rising prevalence of chronic diseases and increasing healthcare expenditure in emerging economies contribute to market growth in the MEA region. However, challenges related to inadequate healthcare infrastructure and economic instability in certain parts of Africa hinder market growth to some extent.

Latin America represents a burgeoning market for IV equipment, supported by improving healthcare infrastructure, rising healthcare expenditure, and growing awareness regarding advanced medical treatments. Countries like Brazil and Mexico are witnessing increased adoption of IV equipment, driven by the rising incidence of chronic diseases and the expanding geriatric population. However, economic uncertainties and regulatory challenges pose hurdles to market expansion in certain Latin American countries. Overall, the global IV equipment market is poised for significant growth across these diverse geographic regions, driven by technological advancements, increasing healthcare expenditure, and the rising prevalence of chronic diseases.

This report provides an in depth analysis of various factors that impact the dynamics of Global Intravenous (IV) Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Healthcare advancements
• Rising chronic diseases
• Increasing surgical procedures

• Technological innovations: In recent years, the global intravenous (IV) equipment market has witnessed a surge in technological innovations aimed at improving patient care and treatment outcomes. One notable trend is the development of smart IV pumps equipped with advanced features such as dose error reduction systems (DERS) and integration with electronic health records (EHR). These pumps help healthcare providers administer medications more accurately, reducing the risk of errors and improving patient safety. Additionally, manufacturers are focusing on enhancing the usability and portability of IV equipment, making it easier for healthcare professionals to deliver intravenous therapies in various settings, including hospitals, clinics, and home care settings.

  Another significant advancement in IV technology is the integration of wireless connectivity and remote monitoring capabilities. This allows healthcare providers to monitor IV therapy remotely, enabling real-time tracking of infusion rates, dosage, and patient vital signs. Remote monitoring not only enhances patient safety by providing early detection of potential complications but also improves efficiency by enabling proactive intervention and adjustment of treatment parameters as needed. Furthermore, advancements in materials science have led to the development of innovative IV catheters and infusion sets designed to minimize discomfort and complications associated with prolonged IV therapy, such as catheter-related bloodstream infections and tissue damage.

  Looking ahead, the global IV equipment market is poised for further innovation and growth, driven by increasing demand for advanced healthcare solutions and the ongoing emphasis on patient-centered care. Emerging technologies such as wearable IV devices, miniaturized infusion pumps, and smart IV catheters hold promise for revolutionizing the delivery of intravenous therapies, offering greater convenience, safety, and efficiency for both patients and healthcare providers. Moreover, as healthcare systems worldwide continue to evolve, there is a growing focus on interoperability and integration of IV equipment with other medical devices and health information systems, paving the way for more seamless and coordinated patient care.

Restraints

• High cost of equipment
• Stringent regulatory requirements
• Limited reimbursement policies

• Risk of infections: The global intravenous (IV) equipment market has witnessed significant growth in recent years, driven by factors such as the rising prevalence of chronic diseases, increasing surgical procedures, and expanding geriatric population. However, alongside these advancements, there exists a persistent concern regarding the risk of infections associated with intravenous therapy.

  One of the primary risks is bloodstream infections, which can occur when pathogens enter the bloodstream through the IV catheter. These infections can lead to serious complications, including sepsis and organ failure, posing a significant threat to patient safety. Despite stringent protocols for catheter insertion and maintenance, healthcare-associated infections remain a prevalent issue, contributing to prolonged hospital stays, increased healthcare costs, and even mortality in severe cases.

  To mitigate the risk of infections in the IV equipment market, healthcare providers and manufacturers are continually innovating to develop safer products and protocols. This includes the use of antimicrobial coatings on catheters, sterile IV sets, and improved insertion techniques. Additionally, healthcare facilities emphasize rigorous hand hygiene practices and regular catheter site inspections to prevent contamination. By integrating these preventive measures into clinical practice, stakeholders aim to enhance patient outcomes and reduce the burden of healthcare-associated infections in the IV equipment market.

Opportunities

• Emerging markets expansion
• Growing geriatric population
• Increasing home healthcare adoption

• Demand for minimally invasive procedures: The global demand for intravenous (IV) equipment has seen a significant surge, primarily driven by the growing preference for minimally invasive procedures across various medical specialties. Minimally invasive techniques have become increasingly favored by both patients and healthcare providers due to their numerous benefits, including reduced recovery times, lower risk of complications, and shorter hospital stays. This trend has propelled the adoption of IV equipment, as it plays a crucial role in delivering medications, fluids, and nutrients directly into the bloodstream with minimal discomfort and trauma to the patient.

  Advancements in technology have revolutionized the design and functionality of IV equipment, making procedures safer, more efficient, and less invasive. Manufacturers are investing heavily in research and development to introduce innovative products that cater to the evolving needs of healthcare professionals and patients. These advancements include the development of smart infusion pumps, which offer features such as dose error reduction systems, wireless connectivity, and integration with electronic medical records, enhancing accuracy and patient safety. Additionally, the rise of wearable infusion devices and portable IV pumps allows patients greater mobility and flexibility during treatment, further driving market growth.

  The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has contributed to the rising demand for IV equipment. Patients with chronic conditions often require long-term intravenous therapy, making reliable and user-friendly infusion devices indispensable in modern healthcare settings. Moreover, the aging population worldwide is fueling the demand for IV equipment, as older adults are more susceptible to chronic illnesses and may require frequent medical interventions. As healthcare systems strive to improve patient outcomes while reducing costs, the adoption of minimally invasive procedures facilitated by IV equipment is expected to continue growing, shaping the future of medical treatment across the globe.

Key players in Global Intravenous (IV) Equipment Market include:

• Becton, Dickinson and Company (BD)
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Baxter International Inc
• ICU Medical, Inc
• Smiths Medical
• Terumo Corporation
• Moog Inc
• Nipro Corporation
• AngioDynamics, Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis